EUVIMEDEUVIMED entdecken
Crossref

Fused Sulfonyl‐[1,2,3]Triazolo[4′,5′:4,5]Pyrido[3,2‐ d ]Pyrimidines: One‐Pot Synthesis, Antibacterial, Antibiofilm, and In Silico Studies

Devireddy Bapureddy, E. Ramya Sucharitha, Ravikumar Kapavarapu, Sirassu Narsimha, Juluru Bhaskar

ChemistrySelect · 2026-11 · 11 (43)

DOI: 10.1002/slct.75185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 16.11.2026. Verfasst von Devireddy Bapureddy und 4 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of fused sulfonyl‐[1,2,3]triazolo[4′,5′:4,5]pyrido[3,2‐d]pyrimidine derivatives was synthesized using an efficient one‐pot Cu(I)‐catalyzed click reaction. The synthesized compounds were assessed for their antibacterial and antibiofilm activities against Gram‐positive strains, specifically Bacillus subtilis , Staphylococcus aureus , and Staphylococcus epidermidis . Compound 1‐(4‐chloro‐3,5‐dimethoxyphenyl)‐5‐tosyl‐4,5‐dihydro‐1H‐[1,2,3]triazolo[4′,5′:4,5]pyrido[3,2‐d]pyrimidine demonstrated significant antibacterial activity, with MIC values ranging from 1.56 to 3.12 µg/mL, comparable to those of dicloxacillin. Compounds 1‐(3,5‐dimethoxyphenyl)‐5‐tosyl‐4,5‐dihydro‐1H‐[1,2,3]triazolo[4′,5′:4,5]pyrido [3,2‐ d ]pyrimidine and 1‐(3,5‐dichlorophenyl)‐5‐tosyl‐4,5‐dihydro‐1H‐[1,2,3]triazolo[4′,5′:4,5]pyrido[3,2‐ d ]pyrimidine demonstrated notable activity, with a minimum inhibitory concentration (MIC) ranging from 3.12 to 6.25 µg/mL. Molecular docking studies targeting PBP2a demonstrated significant binding affinities, with binding energies between −9.8 and −9.1 kcal/mol, exceeding those of standard pharmaceuticals. ADMET analysis demonstrated advantageous drug‐likeness and pharmacokinetic characteristics. These findings indicate that fused triazole–pyrimidine hybrids are promising candidates for antibacterial applications.

Zitieren

APA

Bapureddy, D., Sucharitha, E. R., Kapavarapu, R., Narsimha, S., & Bhaskar, J. (2026). Fused Sulfonyl‐[1,2,3]Triazolo[4′,5′:4,5]Pyrido[3,2‐ d ]Pyrimidines: One‐Pot Synthesis, Antibacterial, Antibiofilm, and In Silico Studies. ChemistrySelect, 11(43). https://doi.org/10.1002/slct.75185

Vancouver

Bapureddy D, Sucharitha ER, Kapavarapu R, Narsimha S, Bhaskar J. Fused Sulfonyl‐[1,2,3]Triazolo[4′,5′:4,5]Pyrido[3,2‐ d ]Pyrimidines: One‐Pot Synthesis, Antibacterial, Antibiofilm, and In Silico Studies. ChemistrySelect. 2026;11(43). doi:10.1002/slct.75185

BibTeX
@article{Bapureddy2026,
  author = {Bapureddy, Devireddy and Sucharitha, E. Ramya and Kapavarapu, Ravikumar and Narsimha, Sirassu and Bhaskar, Juluru},
  title = {Fused Sulfonyl‐[1,2,3]Triazolo[4′,5′:4,5]Pyrido[3,2‐ d ]Pyrimidines: One‐Pot Synthesis, Antibacterial, Antibiofilm, and In Silico Studies},
  journal = {ChemistrySelect},
  year = {2026},
  volume = {11},
  number = {43},
  doi = {10.1002/slct.75185}
}
Kostenlos starten →